Trademark: ASPIRA SYNERGY 2253226
Word
ASPIRA SYNERGY
ID
2253226
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
28 July 2021
Registration Date
28 July 2021
Renewal Date
28 July 2031
Owner(s)
Service
Goods and Services:
Class 44:
Medical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical analysis services for the diagnosis of cancer; providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; DNA screening for medical purposes; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer; medical diagnosis of endometriosis; genetic testing for medical purposes.
Medical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical analysis services for the diagnosis of cancer; providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; DNA screening for medical purposes; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer; medical diagnosis of endometriosis; genetic testing for medical purposes.